Beers, S. A., Cragg, M. S., & Glennie, M. J. (2008). Response: Superior B cell–depleting activity of type II anti-CD20 mAb is not due to activation of complement. American Society of Hematology.
Citación estilo ChicagoBeers, Stephen A., Mark S. Cragg, y Martin J. Glennie. Response: Superior B Cell–depleting Activity of Type II Anti-CD20 MAb Is Not Due to Activation of Complement. American Society of Hematology, 2008.
Cita MLABeers, Stephen A., Mark S. Cragg, y Martin J. Glennie. Response: Superior B Cell–depleting Activity of Type II Anti-CD20 MAb Is Not Due to Activation of Complement. American Society of Hematology, 2008.
Precaución: Estas citas no son 100% exactas.